Lv1
40 积分 2023-09-25 加入
IL-2/CD25: A Long-Acting Fusion Protein That Promotes Immune Tolerance by Selectively Targeting the IL-2 Receptor on Regulatory T Cells
3天前
已完结
Discovery of Lanraplenib (GS-9876): A Once-Daily Spleen Tyrosine Kinase Inhibitor for Autoimmune Diseases
17天前
已完结
Safety and efficacy of fostamatinib in rheumatoid arthritis patients with an inadequate response to methotrexate in phase II OSKIRA-ASIA-1 and OSKIRA-ASIA-1X study
18天前
已完结
Recent Progress of Molecular Design and Activities of Spleen Tyrosine Kinase (SYK) Inhibitors
20天前
已完结
New insights into pre-BCR and BCR signalling with relevance to B cell malignancies
20天前
已完结
Rewiring STAT signaling from the cell surface with Trikine immunotherapeutics
1个月前
已完结
Fostamatinib for the treatment of chronic immune thrombocytopenia
1个月前
已完结
The SYK tyrosine kinase: a crucial player in diverse biological functions
1个月前
已完结
Trastuzumab Deruxtecan plus Pertuzumab for HER2-Positive Metastatic Breast Cancer
1个月前
已完结
Fine Epitope Mapping of the CD19 Extracellular Domain Promotes Design
2个月前
已完结
皖公网安备34019202002308
